SAN DIEGO – August 21, 2017 – Medical Marijuana, Inc. (MJNA) announced that the State of Mexico’s government has purchased the company’s Real Scientific Hemp Oil-X™ (RSHO-X™) CBD hemp oil products from its subsidiary HempMeds Mexico® to treat 11 of its citizens suffering from varying indications including Refractory Epilepsy and Lennox Gastaut-Syndrome. The purchase has the unique distinction of being the first time that a state government in Mexico subsidizes CBD products for patients.
The State of Mexico’s Governor Eruviel Avila distributed HempMeds Mexico’s flagship product RSHO-X™, a CBD hemp oil with zero THC, to the patients at the inauguration of a new clinic located in Ecatepec on August 17th.
“We want to congratulate the State of Mexico’s government for this historic purchase of our RSHO CBD products to help improve the lives of its citizens,” said Medical Marijuana, Inc. Dr. Stuart Titus. Since the State of Mexico subsidizes CBD, patients who otherwise couldn’t afford to purchase and pay for cannabinoid CBD products can access treatment. “[HempMeds’ RSHO-X is] the first and only federally-legal CBD product in Mexico and we are excited about this new historic milestone of being the first Company that the Government of Mexico has contracted [for purchasing CBD].”
“The plethora of benefits of cannabinoids (botanical as well as pharmaceutically developed) in treating multiple indications is now being researched and we are encouraged to see significant anecdotal evidence leading the way,” added Dr. Titus. “Now, health care professionals and government health care agencies are becoming increasingly interested in how CBD hemp oil can help benefit many medical conditions, especially those conditions where conventional medicine has had modest effects.”
Dr. Saul Garza Morales, pediatric researcher and neurologist in Mexico, recently shared the positive results of a recent study he conducted on the effects of Medical Marijuana, RSHO-X™ product in treating children with severe epilepsy, in which 86 percent of the 29 patients he studied experienced statistically significant (greater than 50%) reduction in motor seizures. Seventeen percent of the children were fully seizure free for a 4-month period.
HempMeds® Mexico is the first company to receive government import permits for a cannabis product via approval by the Mexican Health Department, COFEPRIS. With these achievements and other firsts in Latin American countries like Brazil where HempMeds Brasil™ became the first company to offer legal medicinal cannabis products to Brazil after receiving import approval and Paraguay where RSHO™ was the first medical cannabis product approved for import into the country. The cannabidiol products help patients suffering from various conditions including:
- Amyotrophic Lateral Sclerosis
HempMeds® Mexico is a Mexico-based company that made history by being the first company to receive a COFEPRIS federal government import permit for the cannabis product RSHO-X™ for a medical indication. HempMeds® Mexico has worked directly with the Mexican government to safely and legally provide access to CBD hemp oil products. Patients will have immediate access when the State of Mexico subsidizes CBD treatment. To see Medical Marijuana, Inc.’s video statement, click here.
Source: Medical Marijuana, Inc.